Medicaid insurance policies differ from state-to-state. With the appearance of recent, GLP-1 drugs (and others) to deal with weight problems and chubby, there are doubtlessly important well being advantages to be gained. Nevertheless, are State Medicaid Businesses truly overlaying these drugs? That is the query requested by Liu et al. (2024). They use knowledge from public state Medicaid formulary and most popular drug record information to find out if a state coated FDA-approved anti-obesity drugs. The variety of reimbursed prescriptions for every antiobesity medicine was recognized from public 2011-2022 Medicaid State Drug Utilization knowledge.

Usually, some however not all anti-obesity drugs are coated. Furthermore, the more practical GLP-1 drugs are sometimes solely coated if they’re used to deal with diabetes (quite than chubby or weight problems).

Within the first quarter of 2023, 10 of 47 states (21%) with public most popular drug lists coated a minimum of 1 antiobesity medicine; 5 (11%) had unrestricted protection of a minimum of 1 antiobesity medicine…Individually, 39 states (83%) had unrestricted protection of a minimum of 1 of the two diabetes variations of GLP-1 RAs.

https://jamanetwork.com/journals/jama/fullarticle/2816585

The complete article is right here.



Leave a Reply

Your email address will not be published. Required fields are marked *